Mousheng Xu

6.8k citations
14 papers · 577 indexed · h-index 11
Topics
Genetic Associations and Epidemiology (2 papers)Ubiquitin and proteasome pathways (2 papers)Blood groups and transfusion (2 papers)
Partner nations
United StatesChinaCanada

In The Last Decade

Mousheng Xu

14 papers receiving 561 citations

Peers

Mousheng Xu
Comparison fields: 5 of 92
  • Molecular Biology 300
  • Oncology 130
  • Hematology 97
  • Genetics 87
  • Physiology 75
Replace Fujio Takeuchi with:
Fujio Takeuchi Japan
J. Yau United States
Gustavo Jacob Lourenço Brazil
John Dulos Netherlands
J. Wisell United States
Daniel H. Wiseman United Kingdom
Karen Berry United States
Said Baidas United States
Kristina M. Little United States
Maria Yhr Sweden
Mousheng Xu relative to Fujio Takeuchi Japan Fujio Takeuchi's profile →
Citations per field
00.5×1.5×2.5×
Fujio Takeuchi · 1×
Citations per year

Countries citing papers authored by Mousheng Xu

Since Specialization
Citations

This map shows the geographic impact of Mousheng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mousheng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mousheng Xu more than expected).

Fields of papers citing papers by Mousheng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mousheng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mousheng Xu. The network helps show where Mousheng Xu may publish in the future.

Co-authorship network of co-authors of Mousheng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Mousheng Xu. A scholar is included among the top collaborators of Mousheng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mousheng Xu. Mousheng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 45
2 167
3 12
4 4
5 34
6 74
7 63
8 62
9 13
10 69
11 14
12 16
13 1
14
[Study on relationship between human ABO blood groups and type A behavior pattern].
3

About Mousheng Xu

Mousheng Xu is a scholar working on Hematology, Cancer Research and Information Systems and Management, having authored 14 papers that have together received 577 indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (2 papers), Ubiquitin and proteasome pathways (2 papers) and Blood groups and transfusion (2 papers). The work is most often cited by research in Hematology (97 citations), Dermatology (50 citations) and Oncology (130 citations). Mousheng Xu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Peter Kraft, Jennifer A. Perry, Matthew A. Lawlor, Jun Qi, J Chu, Brian M. Wolpin, Susan E. Hankinson, Margaret A. Gates, Wendy Y. Chen and Joshiawa Paulk. Their work appears in journals such as PLoS ONE, Cancer Research and Human Molecular Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026